Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a version update for the page's content or UI.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s displayed revision/version number in the footer was updated from v3.5.2 to v3.5.3, reflecting a minor site release update without altering the study details.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page header.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check93 days agoChange DetectedOnly administrative metadata and revision notes were updated or removed; the ClinicalTrials.gov study content, eligibility criteria, outcomes, and trial timeline remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.